Structure and polymorphisms of human aryl hydrocarbon receptor repressor (AhRR) gene in a French population:: relationship with CYP1A1 inducibility and lung cancer

被引:36
作者
Cauchi, S
Stücker, I
Cénée, S
Kremers, P
Beaune, P
Massaad-Massade, L
机构
[1] Univ Paris 05, Mol Toxicol Lab, INSERM, U490, F-75270 Paris, France
[2] INSERM, Lab Rech Epidemiol & Stat Environm & Sante, U170, Villejuif, France
[3] CHU Sart Tilman, Lab Chim Med, B-4000 Liege, Belgium
来源
PHARMACOGENETICS | 2003年 / 13卷 / 06期
关键词
AhRR; polymorphisms; CYP1A1; inducibility; lung cancer;
D O I
10.1097/00008571-200306000-00005
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Objective The aryl hydrocarbon receptor repressor (AhRR) protein may dimerize with the AhR nuclear translocator (ARNT) and may compete with the aryl hydrocarbon receptor (AhR) to bind the xenobiotic responsive elements. The result is a negative feedback mechanism that involves a down regulation of all genes regulated by the AhR transcription factor which positively regulates the expression of the Cytochrome P-4501A1 gene (CYP1A1). Methods The structure of the AhRR gene was reconstituted, then the genetic polymorphisms of this gene including the promoter were investigated and the link between these polymorphisms, CYP1A1 inducibility and lung cancer incidence in a French population was examined. Four polymorphisms were found, two in the coding region (609G>C and 1977G>C) and two in the 5'-untranslated region (-96G>A and -869A>T). Among the four polymorphisms, only one, the 609G>C has been previously described. The 609G>C and 1977G>C are localized respectively in exon 6 and 12 and lead to Pro554Ala and Asp641 His substitutions, respectively. To evaluate the frequency of these allelic variants, a DNA library of a case-control study of lung cancer (164 controls and 171 patients) was screened. These polymorphisms were detected at the same allele frequency (0.40 for 609C, 0.05 for 1977C, 0.24 for -96A and 0.17 for -869T) in both controls and patients. Statistical analysis did not show any relationship between all the mutations found and CYP1A1 inducibility and lung cancer incidence. Conclusion None of the polymorphisms were found to play a key role in CYP1A1 inducibility or in the susceptibility to develop lung cancer. Pharmacogenetics (C) 2003 Lippincott Williams Wilkins.
引用
收藏
页码:339 / 347
页数:9
相关论文
共 29 条
[1]  
ABE S, 1990, JPN J MED, V29, P164
[2]  
ALEXANDROV K, 1992, CANCER RES, V52, P6248
[3]   Structure and expression of the Ah receptor repressor gene [J].
Baba, T ;
Mimura, J ;
Gradin, K ;
Kuroiwa, A ;
Watanabe, T ;
Matsuda, Y ;
Inazawa, J ;
Sogawa, K ;
Fujii-Kuriyama, Y .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (35) :33101-33110
[4]   Polymorphisms of human aryl hydrocarbon receptor (AhR) gene in a French population:: relationship with CYP1A1 inducibility and lung cancer [J].
Cauchi, S ;
Stücker, I ;
Solas, C ;
Laurent-Puig, P ;
Cénée, S ;
Hémon, D ;
Jacquet, M ;
Kremers, P ;
Beaune, P ;
Massaad-Massade, L .
CARCINOGENESIS, 2001, 22 (11) :1819-1824
[5]   Aryl hydrocarbon receptor signaling plays a significant role in mediating benzo[a]pyrene- and cigarette smoke condensate-induced cytogenetic damage in vivo [J].
Dertinger, SD ;
Nazarenko, DA ;
Silverstone, AE ;
Gasiewicz, TA .
CARCINOGENESIS, 2001, 22 (01) :171-177
[6]   Characterization of the aryl hydrocarbon receptor repressor gene and association of its Pro185Ala polymorphism with micropenis [J].
Fujita, H ;
Kosaki, R ;
Yoshihashi, H ;
Ogata, T ;
Tomita, M ;
Hasegawa, T ;
Takahashi, T ;
Matsuo, N ;
Kosaki, K .
TERATOLOGY, 2002, 65 (01) :10-18
[7]   Mitogen-activated lymphocytes: A good model for characterising lung CYP1A1 inducibility [J].
Jacquet, M ;
Lambert, V ;
Todaro, A ;
Kremers, P .
EUROPEAN JOURNAL OF EPIDEMIOLOGY, 1997, 13 (02) :177-183
[8]   Regulatory interactions among three members of the vertebrate aryl hydrocarbon receptor family: AHR repressor, AHR1, and AHR2 [J].
Karchner, SI ;
Franks, DG ;
Powell, WH ;
Hahn, ME .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (09) :6949-6959
[9]   ARYL-HYDROCARBON HYDROXYLASE IN LYMPHOCYTES AND LUNG-TISSUE FROM LUNG-CANCER PATIENTS AND CONTROLS [J].
KARKI, NT ;
POKELA, R ;
NUUTINEN, L ;
PELKONEN, O .
INTERNATIONAL JOURNAL OF CANCER, 1987, 39 (05) :565-570
[10]   ARYL HYDROCARBON HYDROXYLASE INDUCIBILITY AND BRONCHOGENIC CARCINOMA [J].
KELLERMANN, G ;
SHAW, CR ;
LUYTENKE.M .
NEW ENGLAND JOURNAL OF MEDICINE, 1973, 289 (18) :934-937